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Retrotransposons, mainly LINEs, SINEs, and endogenous retroviruses, make up roughly 40% of 
the mammalian genome and have played an important role in genome evolution. Their prevalence 
in genomes reflects a delicate balance between their further expansion and the restraint imposed 
by the host. In any human genome only a small number of LINE1s (L1s) are active, moving their 
own and SINE sequences into new genomic locations and occasionally causing disease. Recent 
insights and new technologies promise answers to fundamental questions about the biology of 
transposable elements.The seminal discovery that genomes contain pieces of DNA 
capable of moving to new locations challenged prevailing 
notions of genes as static “beads on a string” passed essen-
tially unchanged from one generation to the next. Studying 
mosaic coloration in maize, Barbara McClintock described 
Dissociator and Activator “mutable loci” and with prescience 
called them “controlling elements” that regulate genes. The 
notion was at first poorly received.
Following the discovery of transposons in plants and bacte-
ria, the presence of mobile DNA in eukaryotic species gained 
widespread acceptance. However, the concept of “control-
ling elements” gave way to disparaging terms such as selfish 
DNA and “junk DNA.” Nevertheless, the notion of transposable 
elements as merely molecular parasites, benign at best and 
powerful mutagens at worst, that hijack cellular mechanisms 
for their own selfish propagation, seemed incomplete to some 
biologists. Given that evolution tends to dispose of that which 
is useless and harmful for a species, it was curious that the 
genome should be cluttered with so much “junk.” Now we 
understand that genomes have coevolved with their transpos-
able elements, devising strategies to prevent them from run-
ning amok while coopting function from their presence. Repeti-
tive DNA, and retrotransposons in particular, can drive genome 
evolution and alter gene expression. Evolution has been adept 
at turning some “junk” into treasure.
There are two major groups of so-called “jumping genes” 
(Figure 1). Class II elements or DNA transposons comprise 
about 3% of the human genome and most move by a “cut 
and paste” mechanism. No currently active DNA transposons 
have been identified in mammals. Class I elements comprise 
three groups, all moving in a “copy and paste” manner involv-
ing reverse transcription of an RNA intermediate and insertion 
of its cDNA copy at a new site in the genome. Penelope-like 
elements form a diverse group, are apparently absent in mam-
mals, and are in the very early stages of characterization (Gla-
dyshev and Arkhipova, 2007). Retroviral-like or long terminal 
repeat (LTR) retrotransposons include endogenous retrovi-
ruses, relics of past rounds of germline infection by viruses that Figure 1. Types of Transposable Elements in Mammals
Mariner-like DNA transposons are inactive relics in mammalian genomes. Ret-
rotransposons that contain many, but not all, of the activities necessary for their 
mobility are called autonomous. They are endogenous retroviruses (ERVs) and 
LINEs. The L1 is the only LINE known to be actively mobile in eutherian species. 
Nonautonomous elements, such as Alus and SVAs, are dependent on L1 for 
their mobility. Processed pseudogenes are spliced mRNAs copied and inserted 
in the genome by the L1s. Abbreviations: DR, direct repeat; ITR, inverted ter-
minal repeat; Gag, group-specific antigen (capsid proteins); Prt, protease; Pol, 
polymerase; Env, envelope; RT, reverse transcriptase domain; INT, integrase 
domain; TSD, target site duplication; LTR, long terminal repeat; EN, endonu-
clease domain; C, zinc knuckle domain; An, poly(A); A/B, A- and B-box Pol III 
promoter; SVA, (SINE-R, VNTR, Alu); VNTR, variable number tandem repeats.Cell 135, October 3, 2008 ©2008 Elsevier Inc. 23
lost their ability to reinfect and became trapped in the genome. 
These elements undergo reverse transcription in virus-like par-
ticles by a complex multistep process. The transposition pro-
cess for non-LTR retrotransposons is fundamentally different. 
RNA copies of these elements are likely carried back into the 
nucleus where their reverse transcription and integration occur 
in a single step on the DNA itself.
We focus here on recent discoveries in the biology of the two 
major groups of mammalian non-LTR retrotransposons, LINEs 
(long interspersed nucleotide elements) and SINEs (short 
interspersed nucleotide elements). SINEs are nonautonomous 
elements that do not encode protein and as a consequence 
require LINEs for their propagation. We also consider aspects 
of their biology that remain unclear but that involve important 
questions: How do retrotransposons jump? Where do they 
jump? When do they jump? Why don’t they jump more? And 
what have been the consequences of all that jumping?
A Heavy Genomic Load
Non-LTR retrotransposons are as old as the earliest multicel-
lular organisms, and their 15 clades have origins in the Pre-
cambrian Era of 600 million years ago (Eickbush and Jambu-
ruthugoda, 2008). In mammals, members of four clades are 
known. The RTE (retrotransposable element) clade, absent in 
humans and rodents, includes Bov-B elements from ruminant 
and afrotherians (a diverse clade that includes species such as 
elephants and aardvarks) as well as families prevalent in the 
opossum. LINE2 (L2) elements form 3% of marsupial genomes 
and almost 20% of monotreme (platypus) genomes. Although 
ancient and extinct, L2s occupy greater than 2% of human DNA 
and their impact has probably been significant. For example, 
Donnelly et al. (1999) showed that L2s are capable of acting as 
T cell-specific gene silencers. Low-copy number and degener-
ate CR1/L3 clade members form only 0.05%, 0.3%, and 0.5% 
of mouse, human, and platypus genomes, respectively, but 
have expanded to 2.3% of opossum DNA (Jurka et al., 2005; 
Gentles et al., 2007; Mikkelsen et al., 2007; Warren et al., 2008). 
Comparative analyses reveal significant differences between 
vertebrate lineages in their histories of expansion, contraction, 
and rates of activity for retrotransposon families (reviewed in 
Böhne et al., 2008; see SnapShot by P.K. Mandal and H.H. 
Kazazian in this issue). It seems that genomes differ in their 
abilities to control and coexist with these elements. Little is 
known of the biology of the non-L1 LINEs.
L1s, the only currently active autonomous transposons in 
humans, have been evolving during at least 160 million years 
(Myr) of mammalian radiation. Multiple active lineages of L1s 
coexisted in ancestral primates, but for the past 40 Myr, a 
single unbroken lineage of subfamilies has evolved (Boissinot 
and Furano, 2001; Khan et al., 2006). Expansion of L1s was 
massive, and roughly 500,000 copies occupy about 18% of the 
human genome. From 25 Myr ago the expansion slowed, and 
most insertions are (fortunately) molecular fossils—truncated, 
rearranged, or mutated and incapable of further retrotranspo-
sition. L1 has also been responsible for genomic insertion of 
8000 human processed pseudogenes (many of which are tran-
scribed, often in testes) and over a million SINEs (Zhang et al., 
2003; Vinckenbosch et al., 2006). Most SINE 5′ ends are derived 24 Cell 135, October 3, 2008 ©2008 Elsevier Inc.from Pol III-transcribed small cellular RNAs. B1s and Alus, the 
predominant SINEs of mice and men, originate from a portion 
of the 7SL RNA component of the protein signal recognition 
particle. Alus are about 300 bp in length and have a dimeric 
structure; B1s are monomeric. Other mammalian SINEs, such 
as mouse B2s, have tRNA sequence homology at their 5′ ends, 
and AmnSINEs of chickens and mammals contain both tRNA 
and 5S rRNA-like regions (Nishihara et al., 2006; see Review by 
Kramerov and Vassetzky, 2005). About 40,000 snoRNA/RTE 
LINE-derived chimeric retrotransposons have recently been 
found in platypus (Schmitz et al., 2008).
Many SINEs derived from tRNAs, notably in fish and rep-
tiles, share 3′-end homology with a LINE family member from 
the same genome. In mammals these include Ther-1, Ther-2, 
Mon1, Bov-tA, and Bov-A2 SINEs and their related L2, L3, and 
Bov-B LINEs (reviewed in Ohshima and Okada, 2005). Presum-
ably homologous SINE sequence binds LINE-encoded protein 
to foster retrotransposition, a hypothesis supported by cell 
culture assays with an eel SINE and its corresponding LINE 
(Kajikawa and Okada, 2002). Yet, except for its poly(A) tail, L1s 
lack sequence homology with any SINE.
Hominid genomes also contain SVAs (SINE-R, VNTR, Alu], 
which are composite elements apparently mobilized by L1s. 
Despite their small copy number (3000 in humans), SVAs are 
probably quite active, being highly polymorphic and the cause 
of five known cases of human disease (Ostertag et al., 2003; 
Wang et al., 2005). The coming million years or so will tell if 
SVAs are the “next big thing” in human mobile DNA.
On LINE Chat
The 6.0 kb full-length human L1 has a 900 nucleotide (nt) 5′ 
untranslated region (UTR) that functions as an internal pro-
moter, two open reading frames (ORF1 and ORF2), and a short 
3′ UTR that ends in the poly(A) signal and tail. The mouse L1 
5′ UTR is distinguished by having tandem repeats. An uncon-
ventional termination/reinitiation mechanism translates ORF2, 
which encodes a 150 kDa protein (ORF2p) with endonuclease 
and reverse transcriptase activities (Alisch et al., 2006). More 
attention has focused on the 40 kDa ORF1 protein (ORF1p), 
mostly because it is expressed at much higher levels than 
ORF2p and is easier to study. While mutational analysis has 
shown ORF1p to be essential for retrotransposition, its precise 
role remains unclear, although it forms trimeric complexes and 
possesses nucleic acid chaperone activity in vitro. ORF1p has 
been detected in the cytoplasm and to a lesser degree in nuclei 
of carcinoma and germ cells and has been isolated in ribonu-
cleoprotein (RNP) particles together with L1 RNA and ORF2p 
activity (Martin, 2006; Kulpa and Moran, 2006). Although several 
other proteins coimmunoprecipitate in ORF1p RNPs (Goodier 
et al., 2007), with the exception of a few transcription factors, 
little is known of the non-L1 proteins directly participating in 
the complex process of retrotransposition. Information on L1 
RNP assembly and transport into the nucleus is fragmentary. 
Kubo et al. (2006) found no retrotransposition in quiescent G0 
cells but significant levels in nondividing G1/S phase-arrested 
Gli36 tumor cells, suggesting active RNP transport across the 
nuclear membrane. (L1 biology is reviewed in Moran and Gil-
bert, 2002 and Babushok and Kazazian, 2007.)
Figure 2. How Retrotransposons Affect 
the Cell
Insertions into new locations may be full length or 
5′ truncated (1a) or contain inversions and dele-
tions (1b). Endonuclease-independent insertions 
can also occur at low frequency (1c). Insertions 
may be accompanied by deletion at the insertion 
site (2). Flanking sequence, either 3′ or 5′ to L1, 
may be carried along with the element upon ret-
rotransposition (3 and 4). Mispairing and crossing 
over between LINE or SINE elements can lead 
to deletions or duplications (5). Transcriptional 
pausing can occur within retrotransposon se-
quence, and poly(A) signals within an L1 can lead 
to premature termination of transcription (6). The 
antisense promoter in the L1 5′ UTR can produce 
new transcription start sites for genes upstream 
of the L1 on the opposite strand (7). Splice sites 
within L1s residing in introns can lead to new 
exons within genes (8). L1s can alter the chro-
matin state, thereby altering gene expression (9). 
L1 reverse transcriptase can mobilize Alu, SVA, 
mRNA, and small noncoding RNAs, leading to 
further genome expansion (10). Template switch-
ing of L1 reverse transcriptase from L1 RNA to 
other sequences, such as U6 RNA or Alu RNA, 
can produce chimeric insertions in the genome 
(11) (Buzdin et al., 2007; Garcia-Perez et al., 
2007a). Editing by ADAR of inverted Alus can 
suppress gene expression by nuclear retention 
of the mRNA (12). Alu elements seed formation 
and expansion of microsatellites that have been 
occasionally associated with disease (13) (Arcot 
et al., 1995).It is believed, but not confirmed in vivo, that L1s retrotrans-
pose by target primed reverse transcription (TPRT), a process 
characterized for insect non-LTR retrotransposons. Accord-
ing to this model, L1 ORF2-encoded endonuclease nicks 
the bottom strand of target DNA to expose a 3′-hydoxyl that 
primes reverse transcription of L1 RNA. Second-strand DNA 
synthesis follows, possibly initiated by a second ORF2 mol-
ecule, and the integrant is resolved in a manner still poorly 
understood (Eickbush and Jamburuthugoda, 2008). Consis-
tent with the TPRT model, short target site duplications, but 
occasionally deletions, are generated at the L1 insertion site. 
Evidence from endogenous human insertions and from cell 
culture assays indicates that L1 proteins have cis-preference, 
tending to bind their own encoding RNA. Interestingly, Alus 
and B1s co-opt some, but not all, of the L1 retrotransposi-
tion machinery given that ORF1p is not required for insertion 
(Dewannieux et al., 2003). Clearly a subset of non-L1 RNAs, 
including Pol III transcripts and RNAs associated with the 
nucleolus, are preferred targets for retrotransposition (Buzdin 
et al., 2007). Detailed “ribonomic” studies of the RNA compo-
nents of the L1 RNP are required.
Knowledge of the mechanisms of L1 retrotransposition has 
lagged behind the exquisitely detailed studies of insect R1 
and R2 elements and yeast and bacterial group II introns. Cell 
culture assays available for both L1 and Alu retrotransposi-
tion (Moran et al., 1996; Ostertag et al., 2000; Dewannieux et al., 2003) and improving in vitro assays for L1 endonucleolytic 
cleavage, TPRT, and reverse transcription should move the 
field forward more rapidly (Cost et al., 2002; Kulpa and Moran, 
2006).
On Good and Evil
There are 65 known human disease-causing insertions of L1s, 
Alus, and SVAs. However, simple insertion mutation is but one 
of a startling number of ways that retrotransposons reshuffle 
the genome and alter gene expression, and this list is sure to 
grow (Figure 2; reviewed in Han and Boeke, 2005; Medstrand 
et al., 2005; Belancio et al., 2008).
Retrotransposition occasionally generates target site dele-
tions, some quite large, as illustrated by an L1 insertion that 
obliterated 46 kb of the gene encoding pyruvate dehydroge-
nase complex, component X (PDHX) and caused pyruvate 
dehydrogenase complex deficiency. Another example is the 
deletion of an entire HLA-A gene likely caused by an SVA and 
resulting in leukemia (Gilbert et al., 2002; Symer et al., 2002; 
Mine et al., 2007; Takasu et al., 2007). Nonretrotransposon 
DNA can also be added to the genome by a phenomenon 
termed 3′ transduction (Moran et al., 1999). About 10% to 20% 
of the time, 3′ end processing ignores the weak L1 poly(A) sig-
nal and utilizes instead a downstream signal, causing flank-
ing sequence to be carried along with the retrotransposon to 
the new site of insertion. Less frequently, transcription initiates Cell 135, October 3, 2008 ©2008 Elsevier Inc. 25
from a chance upstream promoter and the L1 mobilizes 5′ flank-
ing sequence. In these ways, retrotransposons may serve as 
vectors for exon shuffling and the creation of new genes. One 
definitive instance involved an SVA transduction of the entire 
AMAC1 (acyl-malonyl condensing enzyme 1) gene to generate 
multiple transcriptionally active copies in the human genome. 
The SINE-R component of the SVA appears to drive transcrip-
tion of the SVA-AMAC chimeras (Xing et al., 2006).
Recombination between retrotransposons causes deletions, 
duplications, or rearrangements of gene sequence. This is 
especially true for Alus, which have been implicated in almost 
50 disease-causing recombination events. Moreover, Alus are 
significantly enriched at boundaries of human segmental dupli-
cations. Mouse segmental duplications are enriched in LTR 
and recent LINE1 retrotransposons but (unlike humans) not 
SINEs (Bailey and Eichler, 2006; She et al., 2008). Compari-
sons of the human and chimp genomes identified more than 
10,000 species-specific transposable element insertions that 
have occurred since these species diverged 6 million years 
ago. About 95% of these inserts were L1s, Alus, and SVAs, 
along with some endogenous retroviruses (summarized in Mills 
et al., 2007). By examining orthologous loci, the Batzer lab has 
estimated the extent of retrotransposon-mediated give and 
take: approximately 900 kb and 7.5 Mb of primate sequence 
lost, respectively, at the sites of Alu and L1 insertions, 400 kb 
of human DNA removed by Alu-Alu recombination, and 53 kb 
inserted by human SVA-mediated DNA transductions (Xing 
et al., 2007). With recent publication of the finished mouse 
genome, draft assemblies for 20 other mammalian species, 
and sequencing of 26 more mammals in progress, a wealth of 
data from comparative analyses is coming soon.
The greatest impact of retrotransposon insertions may be 
on the expression of nearby genes. Ongoing retrotransposition 
peppers genomes with new splice sites, adenylation signals, 
promoters, and transcription factor-binding sites that can reor-
ganize gene expression and build new transcription modules, 
as hypothesized by Britten and Davidson (1971) over 35 years 
ago. For instance, a mouse B1 subfamily (B1-X35S) is distin-
guished by three mutations that recruit transcription factors 
Slug and dioxin receptor Ahr, causing repression of physiologi-
cally important genes (Roman et al., 2008).
The recent discovery that thousands of DNA fragments are 
highly conserved in sequence and sometimes synteny among 
evolutionarily distant vertebrate genomes, and that many of 
these fragments originate from transposable elements, espe-
cially SINEs and LINEs, has sparked interest in the field. Such 
conservation by strong purifying selection predicts function. 
Several superfamilies of these preserved sequence bits have 
been identified, and with them intriguing tales of exaptation (the 
adoption of a feature that had a different function in its ancestral 
form). For example, some SINEs contain a conserved central 
65 bp “core.” These were first described as mammalian-wide 
interspersed repeats (MIRs) and are now considered members 
of the CORE-SINE superfamily. The pro-opiomelancortin gene 
neuronal enhancer nPE2 is a CORE-SINE (Santangelo et al., 
2007). Bejerano et al. (2006) discovered that members of the 
ancient LF (lobed-fin) SINE family, conserved in sequence in 
coelacanth fish and land tetrapods, have been exapted as 26 Cell 135, October 3, 2008 ©2008 Elsevier Inc.exon fragments, and apparently in one instance as the distal 
enhancer of the neuro-developmental gene ISL1. This same 
group also found that >10,000 conserved mammalian transpo-
son sequences are preferentially retained near genes involved 
in the regulation of transcription and development (Lowe et al., 
2007). Most recently, AmnSINEs, members of the Deu-SINE 
superfamily, have been shown to exert enhancer activity on 
Fgf8 and Satb2 gene expression in the developing mammalian 
forebrain (Sasaki et al., 2008).
The L1 is especially adept at disrupting transcription of its 
host genes. L1 sequences are found in the noncoding regions 
of about 80% of human genes, and L1 density inversely cor-
relates with mRNA expression of those genes. Resident L1s 
cause pausing in transcriptional elongation and premature 
transcript termination due to cryptic polyadenylation signals 
(Perepelitsa-Belancio and Deininger, 2003, Han et al., 2004). 
Possessing functional promoters on the sense and antisense 
strands of its 5′ UTR, an L1 can also initiate both upstream and 
downstream transcription. Many transcripts in the expressed 
sequence tag (EST) databases originate from the antisense 
promoter, which may even regulate tissue-specific expression 
of some genes (Mätlik et al., 2006). Promoter co-option is not 
limited to L1s. Analyzing a cluster of microRNA genes on human 
chromosome 19, Borchert et al. (2006) found some transcribed 
by upstream Alu Pol III promoters, as well as 50 others overlap-
ping Alus and other repeats. Indeed, high-throughput analyses 
of cDNA ends reveal that tens of thousands of antisense tran-
scripts originate from both class I and class II transposable 
elements sitting within genes (Conley et al., 2008).
Sequence from transposable elements may be captured and 
incorporated into gene mRNAs, a process called “exonization.” 
It has been estimated that 5% of human alternatively spliced 
internal exons originate in Alus, a phenomenon fostered by 
“pseudosplice sites” and occasionally RNA editing that alters 
the nucleotide sequence of transcripts (for reviews see Häsler 
et al., 2007 and Sorek, 2007). A recent comprehensive study 
by Zhang and Chasin (2008) confirms that high copy number 
repeats are the most important sources of new genes in humans 
and mice, and by implication new proteins. Nekrutenko and Li 
(2001) claimed that 4% of human protein coding regions con-
tained transposable element sequence (mostly L1s and Alus), 
although Gotea and Makalowski (2006) believed 0.1% a more 
reasonable estimate, arguing that most alternative transcripts 
containing transposable elements do not generate actual pro-
tein. Others make different assumptions and place the num-
ber significantly higher (reviewed in Piriyapongsa et al., 2007). 
Retrotransposons may also be exapted as noncoding genes, 
as in the case of the primate BC200 small RNA gene that origi-
nated from an Alu and the analogous rodent BC1 gene that 
derived from a retrotransposed tRNA (and itself subsequently 
spawned a subclass of ID SINEs). Both BC1 and BC200 small 
RNAs function as translational repressors in neurons by tar-
geting the catalytic activity of factor eIF4A (Volff and Brosius, 
2007; Lin et al., 2008).
Retrotransposon-mediated pseudogene insertions have 
also exonized to create functional fusion genes. Retrotrans-
position of mRNA from an X-linked gene into the intron of an 
autosomal gene generated a bicistronic and new retrogene 
product, Utpl46, important in mouse spermatogenesis. Intrigu-
ingly, X-to-autosome retrotransposition is not uncommon, 
and it has been proposed as a mechanism that modulates 
gene dosage effects of X chromosome inactivation (Bradley 
et al., 2004). The POTE group 3 fusion gene subfamily formed 
after an actin pseudogene inserted immediately downstream 
of a POTE gene precursor prior to the Old World monkey/
ape divergence (Lee et al., 2006). Retrotransposition of the 
cyclophilin gene into an intron of TRIM5 created a fusion gene 
that explains resistance of the owl monkey to HIV-1 infection 
(Sayah et al., 2004). Also, Babushok et al. (2007) described 
how intergenic splicing of two RNAs transcribed from neigh-
boring genes (which encode phosphatidylinositol-4-phos-
phate 5-kinase, PIP5K1A, and the 26S proteasome subunit, 
PSMD4) generated a single RNA template that was reverse 
transcribed and inserted into the genome of an early homi-
noid as a fusion retrogene.
Overexpressing L1 ORF2 protein may be bad for the cell. 
Gasior et al. (2006) transiently transfected an L1 construct 
into tumor cells and discovered double-strand chromosome 
breaks in numbers significantly greater than expected for tar-
get-primed reverse transcription alone. Damage depended 
upon an intact endonuclease domain and the DNA damage-
response kinase ATM (although the effect disappeared by 
48 hr). The results are consistent with the observation that 
L1 overexpression may induce apoptosis and senescence in 
some cell lines (Belgnaoui et al., 2006; Wallace et al., 2008). 
Although these observations require validation in vivo, if 
endogenous L1 expression induces chromosome breaks 
independent of retrotransposition, this implies a greater role 
for L1s than previously thought in fostering recombination and 
translocation. Such genetic instability would be aggravated 
in germ cells, stem cells, and cancers where L1 expression is 
highest (see below).
The Search for Meaning
The increasing number of documented instances of gene 
expression modified by transposable elements support 
McClintock’s original hypothesis but still do not explain why 
the cell has allowed so many mobile elements to accumulate 
while evolving multiple strategies to control their activity (as 
discussed below). The hunt is on for a more overarching expla-
nation of why half our genome is not just half junkyard. Several 
studies report that expression of retrotransposon RNA and 
proteins has marked effects on cell function and metabolism.
Endogenous reverse transcriptase activity has been detected 
in some tumors and patients with certain pathologies. Follow-
ing upon studies identifying elevated reverse transcriptase 
activity in spermatozoa, epididymis, oocytes, and early-stage 
embryos (Evsikov et al., 2004; Crowell and Kiessling, 2007), the 
Spadafora lab investigated effects of inhibiting this activity with 
antireverse transcriptase antibodies, the nonnucleoside inhibi-
tor nevirapine, and siRNA against L1s and human endogenous 
retroviruses (HERVs) and posited intriguing roles for endoge-
nous reverse transcriptase in early normal embryonic develop-
ment, cell differentiation, and tumor progression (Spadafora, 
2008). A caveat is the difficulty of controlling off-target effects 
in broad-based inhibition studies, especially when so many transposable elements reside in genes. Also, a recent study 
reported inhibition of L1 retrotransposition in cell culture by 
nucleoside analog reverse transcriptase inhibitors but not by 
nevirapine (Jones et al., 2008).
The relationship between retrotransposons, DNA damage, 
and cell stress is poorly understood. Genotoxic poisons, radia-
tion, heat shock, viral infection, and heavy metals all induce 
SINE or LINE expression (Li et al., 1999; Kale et al., 2006; 
reviewed in Farkash and Prak, 2006). This raises the ques-
tion of why a cell under duress would permit upregulation of 
mobile elements whose mutagenicity might compound dam-
age inflicted by the original stress. Perhaps they play some role 
in coping with stress (see Capy et al., 2000).
Upon heat shock, transcription of many housekeeping 
genes is repressed while temperature response genes, such 
as the chaperone HSP70, are activated. Recent investigations 
suggest that coincident increase in SINE transcription may be 
part of this adaptive response. The Kugel and Goodrich groups 
showed in vitro that mouse B2 RNA and human dimeric Alu 
RNA occupied promoters of heat shock-repressed genes, 
bound Pol II at high affinity, and caused its inactivation at these 
promoters. Repression was partially relieved by an antisense 
oligonucleotide against the Alu RNA. Alu RNAs were not found 
at the promoters of activated HSP70 or U2 genes (Mariner et 
al., 2008). Translation inhibition likely requires Alu RNA to be 
bound in an RNP with signal recognition particle (SRP) 9/14 
proteins (Häsler and Strub, 2006).
Retrotransposons have also been linked to DNA-damage 
repair. Morrish et al. (2002) demonstrated an endonuclease-
deficient pathway of L1 integration in Chinese hamster ovary 
(CHO) cells defective in nonhomologous end-joining (NHEJ) 
double-strand break repair. Furthermore, in CHO cells 
impaired for both NHEJ and telomere maintenance due to 
DNA-PKcs deficiency, L1s integrated at dysfunctional telom-
eres, leading the authors to propose that endonuclease-
independent retrotransposition is an ancestral remnant of 
an RNA-mediated DNA-repair mechanism extant before the 
acquisition of endonuclease by non-LTR retrotransposons 
(Morrish et al., 2007). Endonuclease-independent insertions 
are indeed seen in the human genome, although only one de 
novo human L1 insertion at a breakpoint has been reported 
(Sen et al., 2007, Liu et al., 1997). In yeast, double-strand 
break repair by Ty1 LTR retrotransposons is well known. 
Drawing a connection between telomere targeting and ret-
rotransposons across a broad swath of eukaryota, a subset 
of Penelope-like retrotransposons that lack endonuclease 
but share common ancestry with TERT (telomerase reverse 
transcriptase) have been found at telomeres in rotifers, fungi, 
stramenopiles, and plants. HeT-A, TART, and Tahre non-LTR 
retrotransposons play a critical role in telomere maintenance 
in the fruit fly Drosophila, a species without active telom-
erase (Pardue et al., 2005; Gladyshev and Arkhipova, 2007). 
Indeed, TERT, which maintains the ends of chromosomes in 
most species, itself is thought to derive from an ancient non-
LTR retrotransposon (Nakamura and Cech, 1998).
In placental mammals, L1 sequences may play a role in 
X-inactivation, the process of silencing many genes on one 
X chromosome early in female embryogenesis. Inactivation Cell 135, October 3, 2008 ©2008 Elsevier Inc. 27
Figure 3. How the Cell Affects Retrotrans-
posons
Truncation, mutation, and rearrangement inacti-
vate the L1 (1). Methylation of the L1 5′ UTR inhib-
its expression in cells (2). Pausing and premature 
termination of transcription inhibits L1 expression 
(3). Heterochromatization of L1s and Alus sup-
presses expression (4). Double-strand RNA pro-
duced by transcription from both the sense and 
antisense promoters may inhibit L1 retrotrans-
position by an RNA interference mechanism (5). 
Small piRNAs inhibit L1 expression in germ cells 
(5). ORF1 protein and L1 RNA may be seques-
tered in stress granules in the cytoplasm (6). Vari-
ous APOBEC3s reduce L1 retrotransposition in 
cell culture by an unknown mechanism unrelated 
to cytosine deamination. It is unclear whether the 
effect occurs in the nucleus or cytoplasm (7). Alus 
are altered by ADAR RNA editing (8). TREX1, a 
DNA nuclease, prevents accumulation of retro-
element reverse-transcribed single-strand DNA. 
Although predominantly cytoplasmic, TREX1 can 
translocate to the nucleus, its presumed site of 
action on L1 single-stranded DNA (ssDNA) (9). 
MAEL, present in the chromatoid body in male 
germ cells, induces silencing of retrotransposons 
in mice (10).involves the activity of XIST, a small noncoding RNA that coats 
the inactive X. Mary Lyon hypothesized that L1 sequences 
function as “booster” elements, cis-acting sequences foster-
ing the spread of inactivation. Indeed, L1s are enriched on the 
X chromosome and their density correlates with the degree of 
inactivation, although interaction of L1s and XIST RNPs remains 
to be shown. Marsupial species lack an XIST homolog, and L1 
density is not enriched on the opossum X (Mikkelsen et al., 
2007; reviewed in Lyon, 2006).
With so many ways that insertions of transposable ele-
ments can influence genes, a modest increase in transposi-
tion could drive evolutionary change at a rate not possible 
by random nucleotide mutation. This could advantage a spe-
cies faced with a deteriorating environment and the need to 
adapt or die. Slotkin and Martienssen (2007) noted, “stress-
reactivated TEs (transposable elements) might generate 
the raw diversity that a species requires over evolutionary 
time to survive the specific stress,” and harkened back to 
Barbara McClintock who proposed that transposons were 
activated in response to genomic challenge. Interestingly, 
Ohshima et al. (2003) discovered simultaneous bursts of 
Alu and processed pseudogene amplifications 40 to 50 Myr 
ago, coincident with the radiation of the higher primates and 
possibly linked with the activity of several L1 subfamilies. 
Using a smaller data set, Devor and Moffatt-Wilson (2003) 
identified additional pseudogene peaks at 38 Myr ago, fol-
lowing the Catarrhini divergence, and 23 Myr ago, a time 
when hominoid species began to appear. Investigation of 
more genomes should show if transposition bursts acceler-
ate speciation.28 Cell 135, October 3, 2008 ©2008 Elsevier Inc.Preemptive Strikes
Given that retroelements affect the genome in so many ways, 
it is not surprising that the cell has marshaled various forces 
to regulate their activity (Figure 3). Foremost is transcript 
malformation due to splicing and premature polyadenyla-
tion (as described above) and DNA methylation. A majority of 
methylated cytosines in human genomic DNA occur in repeti-
tive sequences, and indeed it has been proposed that DNA 
methylation evolved primarily as a defense mechanism against 
transposable elements (Yoder et al., 1997). Maintenance DNA 
methyltransferase Dnmt1, and de novo methyltransferases 
Dnmt3a and Dnmt3b, are all involved in methylation of intracis-
ternal A particle (IAP) retrotransposons in mouse embryos and/
or germ cells (Walsh et al., 1998; Kato et al., 2007). Dnmt3L, a 
Dnmt3a/b homolog without a catalytic domain, is expressed 
in premeiotic spermatagonia and when absent causes com-
plete loss of post-zygotene spermatocytes. Male mice lacking 
Dnmt3L display hypomethylation at the promoters of both IAPs 
and L1s and a dramatic increase in their transcription in sper-
matocytes and spermatagonia (Bourc’his and Bestor, 2004). 
In an analogous manner, germ cells of female mice lacking 
lymphoid-specific helicase (Lsh) show defective chromosome 
synapsis and hypomethylation with loss of IAP silencing. Lsh is 
a homolog of Arabidopsis Ddm1 (decrease in DNA methylation 
I), a SNF2 ATPase-type gene that promotes chromatin conden-
sation and transposon silencing (De La Fuente et al., 2006).
Chromatin condensation may suppress the activity of 
transposable elements. Conversely, structural change initi-
ating within transposable elements may nucleate local DNA 
structure. Methylation spreads from plant SINEs into flanking 
regions. Mouse B1 SINEs can also act as “methylation cen-
ters,” and methylation spreading from human Alus has been 
implicated in silencing some tumor suppressor genes (Graff 
et al., 1997; Arnaud et al., 2000). At the chromatin level, Kondo 
and Issa (2003) found Alus to be a target for H3K9 histone 
methylation. On the other hand, Martens et al. (2005) detected 
enriched lysine methylation at mouse satellite repeats and IAP 
retrotransposons but not at L1s and only weakly at B1s. Such 
studies assay average histone modifications across a genome; 
most informative would be comparisons of local chromatin 
structure at individual loci polymorphic for an insertion, or in cell 
culture lines in which a retrotransposon is present or absent. 
Although promiscuous spread of altered chromatin can engulf 
and repress proximal genes, one may also speculate that the 
numerous repetitive elements scattered about the genome 
play a role in organizing higher-order chromatin structure.
It has been proposed that RNA-induced silencing is an 
ancient form of immunity that evolved to quell viruses and 
transposable elements. Control of transposable elements by 
RNA intereference (RNAi) was identified first in plants and 
subsequently in other eukaryotes. Micro-RNAs (miRNAs) and 
small-interfering RNAs (siRNAs) are cleaved from short hairpin 
and double-stranded RNA precursors by Dicer endonucleases 
and bound by Argonaute proteins in a large multiprotein com-
plex called RISC. RISC is targeted to homologous sequence in 
cellular RNAs, forcing their degradation or suppressing transla-
tion. Transcription of murine L1 and IAP elements is elevated in 
embryonic stem cells of Dicer knockout mice (Kanellopoulou et 
al., 2005). Interestingly, about 12% of miRNAs in the mirBASE 
database have significant homology with all classes of trans-
posable elements—L2, MIR, and DNA transposon sequences 
being most common. Also, almost 30 human miRNAs share 5′ 
seed target complementarity to a conserved site within Alus 
(Smalheiser and Torvik, 2005, 2006). The presence of transpo-
sons within mRNAs means that many genes may also be regu-
lated by miRNAs related to transposable element sequence.
Forward and reversed retrotransposons sitting within tran-
scribed genes, along with both sense and antisense activity from 
the promoter of the L1 5′ UTR, predict a pool of double-stranded 
RNAs available for siRNA production. Recent deep sequencing of 
small RNA libraries from mouse oocytes found a preponderance of 
L1, LTR retrotransposon, and pseudogene fragments (Watanabe 
et al., 2008; Tam et al., 2008). Cotransfecting L1 siRNAs diced in 
vitro with an L1 active in cell culture reduced its retrotransposition 
(Soifer et al., 2005). Depletion of Dicer in cultured cells doubles L1 
retrotransposition, although transcription is modestly increased 
(Yang and Kazazian, 2006). Double-stranded small RNAs hybrid-
izing with probes from the L1 5′UTR were detected but not con-
firmed as bona fide siRNAs. Whether or not siRNAs suppress L1s 
remains an open question.
Evidence is stronger that a second class of small RNA 
silences mammalian retrotransposons. In Drosophila, the Piwi 
group of Argonaute proteins bind 26  to 31 nt piRNAs that are 
enriched in sequences of retrotransposons and other repeti-
tive elements. piRNAs are apparently not derived from double-
strand RNA precursors but from single-strand RNA transcribed 
from piRNA gene clusters. Disruption of piRNA pathways 
causes marked derepression of retrotransposons in the Dros-ophila male germline (reviewed in Klattenhoff and Theurkauf, 
2008). Deletion of two RNAs, Nct1/2 within a piRNA cluster on 
mouse chromosome 2, increased L1 RNA and ORF1p expres-
sion many fold in spermatocytes (Xu et al., 2008). Mouse Piwi 
proteins, Mili, Miwi, and Miwi2, are important for spermatogen-
esis. Although initial studies reported that their bound piRNAs 
are depleted in repeat-derived sequences in pachytene-stage 
male germ cells, more recent experiments have identified pre-
pachytene and fetal germ cell piRNAs enriched in repeats. 
Loss of Mili and Miwi2 impairs de novo IAP and L1 promoter 
methylation, together with a reduction in repeat-associated 
piRNAs and derepression of retrotransposon transcription in 
male germ cells of newborn mice (Kuramochi-Miyagawa et al., 
2008; reviewed in O’Donnell and Boeke, 2007, Aravin et al., 
2007; Girard and Hannon, 2008). The mechanism linking piR-
NAs with DNA methylation is not understood.
Both L1 RNA and ORF1 protein accumulate in stress gran-
ules, which are cytoplasmic aggregates that form in stressed 
cells to store inactive RNAs and occasionally target them for 
degradation (Goodier et al., 2007; J.L.G., unpublished data). 
One interpretation is that cells sequester L1 RNPs so they do 
no harm. Stress granules are associated with another somatic 
RNA granule, the processing body (P body), and share compo-
nents including members of RISC. In male germ cells of mice, 
the perinuclear chromatoid body is analogous to P bodies and 
is a reservoir for miRNAs and Argonaute/Dicer proteins (Kotaja 
et al., 2006). It is also the abode of MAEL protein (homolog of 
the Drosophila nuage protein Maelstrom), recently shown to 
be important for suppression of retroelement transcription in 
testes and control of IAP and L1 retrotransposition in cell cul-
ture (Soper et al., 2008). Loss of MAEL also results in impaired 
DNA methylation and spermatogenesis, drawing an interesting 
parallel with the phenotypes of mice lacking Mili or Miwi2.
Another component of the cell’s arsenal for retrotransposon 
control is nucleic acid editing. The single cytosine deaminase 
gene Apobec3 in rodents has expanded to seven variants in 
the primate lineage. APOBEC3G was first identified through 
its ability to inhibit HIV strains with defective vif (viral infectiv-
ity factor) genes by causing C to U hypermutation of minus 
strand DNA. Human APOBEC3A, 3B, 3C, and 3F are inhibi-
tors of LINE-1 retrotransposition in cell culture. The effect of 
APOBEC3G on L1s is uncertain due to contradictory evidence, 
although it strongly downregulates Alu retrotransposition. 
Intriguingly, suppression of Alu, L1, and mouse IAP and musD 
LTR retrotransposons by APOBEC3 proteins is not accom-
panied by hypermutation and in the case of Alu inhibition 
does not even require an active cytosine deaminase domain. 
This alternative path of APOBEC activity, which may involve 
sequestering retrotransposon RNAs in high-molecular-weight 
cytoplasmic complexes, requires more detailed investigation 
(summarized in Schumann, 2007; Chiu and Greene, 2008).
In contrast to the APOBEC family, the ADAR (adenosine 
deaminase acting on dsRNA) family of RNA-editing enzymes 
catalyzes adenosine to inosine changes in double-stranded 
RNA. In the human genome extensive editing of the noncod-
ing region of genes occurs largely within Alus, as well as some 
LINEs. Mouse B1 SINEs are edited but to a lesser degree. ADARs 
bind nonspecifically to any dsRNA, and Alus may be favored Cell 135, October 3, 2008 ©2008 Elsevier Inc. 29
targets due to their dimeric structure and occasional head-to-
tail orientation (reviewed in Nishikura, 2007). An examination of 
two genes, NicolinI and Lin28, found that inverted Alus in their 
3′ UTRs were hyperedited and suppressed expression of the 
genes in a manner correlated with nuclear retention by binding 
protein p54nrb. This phenomenon might be extrapolated to some 
of the 333 other genes that also contain inverted Alus in their 
3′ UTRs (Chen et al., 2008). Although a role for ADAR editing in 
the control of transposable elements remains unclear, intriguing 
connections with chromatin remodeling and repression of inter-
fering RNA production have been proposed (Nishikura, 2007).
Viral nucleic acids trigger interferon production, a critical 
component of the immune response to infection. It is desirable, 
however, that RNA and cDNA from endogenous retroelements 
do not, as overproduction of interferons may initiate autoim-
mune disease. A new study by Stetson et al. (2008) revealed 
that the 3′-5′ exonuclease TREX1 targets reverse-transcribed 
single-strand DNA and prevents its accumulation in mice. Over-
expression of TREX1 dramatically reduced retrotransposition 
rates of L1 and IAP elements in cell culture. This raises interest-
ing questions, such as how TREX1 complexes recognize their 
nucleic acid targets, and what part reverse transcriptases may 
play in autoimmunity.
Losing Control
Suppression of retrotransposition is relaxed in some cell 
types. Early studies detected L1 ORF1p and full-length RNA 
transcripts in mouse embryonal carcinoma cells and testicular 
germline tumors, and in several human tumorigenic cell lines, 
but rarely in differentiated somatic cells. Cell culture retrotrans-
position assays also detect robust retrotranspositon in many 
tumor lines but not in most primary nontransformed cells. The 
reasons for repression in normal cells are unclear, but it is pos-
sible that mutations that predispose a cell to become cancer-
ous also activate retrotransposition. Failure of transcriptional 
control might occur for a number of reasons. Altered miRNA 
profiles and reduced ADAR editing characterize some tumor 
phenotypes (Paz et al., 2008). Dramatic changes in global 
methylation, with consequent repatterning of the transcrip-
tome, frequently involve hypomethylation of Alus, LINEs, and 
HERVs, although it remains untested if this demethylation 
leads to increased endogenous retrotransposition. Elevated 
retrotransposition within a developing cancer could alter the 
tumor phenotype or hasten tumor progression (discussed in 
Schulz, 2006; Hauptmann and Schmitt, 2006). Furthermore, an 
unlucky hit into a tumor suppressor gene of a normal cell could 
set it on the path to cancer, as apparently occurred in a case of 
colon cancer (Miki et al., 1992). Synergy between retrotranspo-
sition and cancer remains an unexplored question.
If we think of retrotransposons as genetic parasites, it makes 
sense that they should evolve to be active in the germ line, and 
so pass on to future generations, but remain inactive in somatic 
cells and not risk harming the host. This notion is challenged 
by recent evidence for activity in certain normal somatic cells. 
Elevated levels of L1 protein have been detected in human tes-
ticular vascular endothelial and Leydig cells (Ergun et al., 2004). 
Employing a chimeric L1-adenoviral delivery system to improve 
transfection, Kubo et al. (2006) detected retrotransposition 30 Cell 135, October 3, 2008 ©2008 Elsevier Inc.(>2%–3%) in primary fibroblasts and hepatocytes. Cultured 
human embryonic stem cells support some retrotransposi-
tion (Garcia-Perez et al., 2007b). Muotri et al. (2005) reported 
a propensity for retrotransposition in neuronal progenitor cells 
in cell culture, and in a mouse transgenic for a human L1, and 
speculated that derepressed retrotransposition could contrib-
ute to neuronal plasticity and “uniqueness of individuals within 
a population.” Equally likely, however, are insertion-induced 
neural pathologies, including cancer.
Expression of some retrotransposons is high in late oocytes 
and early-stage embryos, diminishing in later stages. Peas-
ton et al. (2004) found that 13% of transcripts from mouse 
EST libraries of late-stage oocytes contained sequence from 
transposable elements, most often beginning within LTRs of 
MaLR and endogenous retrovirus-L class retrotransposons 
and extending into flanking sequences. Erasure of methylation 
during preimplantation development may open windows of 
opportunity for retrotransposition. Of course, retrotransposons 
can only become established in the genome if insertion occurs 
in germ cells or their progenitors, or in early-stage embryonic 
cells destined to become germ cells. Male germline insertions 
have been observed in two mouse models of human L1 ret-
rotransposition, and early somatic insertion in a third, although 
in each case the transgene included a heterologous promoter 
with unknown effects on cell-specific activity (Ostertag et al., 
2002; Prak et al., 2003; An et al., 2006). More recent transgenic 
mouse and rat studies in our lab also suggest that retrotrans-
position is elevated in early embryogenesis (H.K. and H. Kano 
et al., unpublished data). On the clinical side, an insertion into 
the CYBB gene of one patient caused chronic granulomatous 
disease and revealed that retrotransposition may occur either 
during meiosis I in female germ cells or in the early embryo 
(Brouha et al., 2002). A second patient suffering from X-linked 
choroideremia caused by a full-length L1 insertion led to the 
discovery that the mother was both a germline and somatic 
mosaic, evidence that retrotransposition can occur early in 
human embryonic development (van den Hurk et al., 2007). 
These observations lead us to speculate that retrotranspo-
sons, along with other known factors such as toxins and 
chromosome abnormalities, may contribute to the high rate of 
spontaneous abortions (estimated at 50% of pregnancies) that 
occur in humans.
Valuable information concerning mobile element regula-
tion and cell development will be gained by profiling de novo 
insertion events in tumor versus normal cells, in the develop-
ing embryo, in differentiating stem cells, and so on. Techniques 
for “fingerprinting” and isolating new L1 insertions have been 
described and are being refined (Sheen et al., 2000; Badge et al., 
2003). Deep sequencing techniques, such as 454/Roche and 
Solexa/Illumina, together with tiling array and other microarray 
technologies, are the new tools available for rapidly cataloguing 
novel retrotransposition events across entire genomes.
Private LINEs, Private SINEs
The Human Genome Project and subsequent sequenc-
ing efforts revealed only 0.1% variation among individual 
genomes. Pairs of individuals from different populations are 
often more similar than pairs of individuals from the same 
population, supporting a recent evolutionary origin for mod-
ern humans. It is comforting that we are all essentially the 
same under the skin.
Much of the individual genome variation that does exist is due 
to chromosome rearrangements, copy number variants, single-
nucleotide polymorphisms (SNPs), and repetitive elements. 
Although the Human Genome Project indicated about 2000 L1s 
and 7000 Alus specific to humans, in reality the number is far 
greater due to individual polymorphisms and ongoing retrotrans-
position. Up to 5% of newborn children are estimated to have a 
new retrotransposon insertion (Cordaux et al., 2006). Bennett et 
al. (2004) examined DNA sequencing trace data derived from 36 
humans from diverse populations to identify 25% to 35% of the 
more than 2000 estimated transposon-related insertion/deletion 
(indel) polymorphisms. Akagi et al. (2008) found inbred mouse 
strains to have a significantly greater number of transposable 
element indels, most due to L1s, and consistent with many more 
potentially active mouse L1s than human L1s (Goodier et al., 
2001; Zemojtel et al., 2007). Interestingly, L1 activity appears to 
have been extinguished in some South American rodents and 
megabats (Cantrell et al., 2008).
Ongoing activity of retrotransposons, their random and stable 
integration, and their essentially homoplasy-free nature have cre-
ated a pool of polymorphic and fixed alleles that are increasingly 
valuable for evolution, population, and forensic analyses (reviewed 
in Xing et al., 2007). How many polymorphic elements are active 
in a human genome? Brouha et al. (2003) determined that 44% of 
young intact L1s were polymorphic for presence in the genome 
and that about half of these were capable of retrotransposition 
in cell culture, predicting 80 to 100 potentially retrotransposition-
competent L1s in the average diploid genome. Interestingly, only 
a small number are very active, or “hot,” for retrotransposition, 
and these have accounted for most de novo insertions. How-
ever, when several of these “hot” Ta-1 L1s were examined across 
diverse human populations, considerable individual allelic varia-
tion affected their ability to retrotranspose (Seleme et al., 2006). 
Epigenetic variation in methylation and chromatin structure may 
partially account for variation in the regulation of some homolo-
gous retrotransposons between different individuals. Mapping 
a person’s unique complement of mobile DNA, their “transpo-
some,” and its activity is a hot topic being pursued in several labs. 
It would not be unreasonable to expect that when various human 
populations are analyzed, the total extant number of active L1s 
may be in the hundreds of thousands.
Gene expression levels, termed “the expression phenotype,” 
are both highly variable and heritable in humans and other spe-
cies. Morley et al. (2004) assayed CEPH cell lines from 14 pedi-
grees and found 3554 genes that varied in expression levels. It 
is unclear to what degree polymorphic transposable elements 
exert an effect, but it could be significant. Variegating repression 
of allelic transposable elements can cause tissue or individual dif-
ferences in the silencing of proximal genes. The phenomenon of 
“transcriptional interference” was dramatically illustrated when a 
mouse IAP inserted upstream of the yellow agouti gene and, due 
to differential methylation of a cryptic promoter in the IAP, caused 
an extreme range of coat colors in the offspring of an isogenic 
strain. The maternal epigenetic state was partially inherited, 
whereas methylation patterns were erased in the male germline (Morgan et al., 1999). Similarly, phenotypic variation in Axin-fused 
(AxinFu) allelic mice, manifested as kinked tails, correlated with dif-
ferential methylation of an adjacent IAP LTR and in this case was 
passed through both the male and female germlines (Rakyan et 
al., 2003). Examples such as these support the notion that trans-
posable elements in mammalian genomes cause considerable 
cellular phenotypic variation, making each individual a “com-
pound epigenetic mosaic” (Whitelaw and Martin, 2001).
Epilogue
Mobile DNA has been described as the genome’s “dark mat-
ter”: a significant part of its mass, difficult to understand, and 
often ignored. Transposable elements may also be seen as “dark 
energy,” a dynamic force that not only accelerates expansion but 
also helps set the warp and weft of genomes, for better and for 
worse. Transposable elements arose as intracellular parasites 
that became domesticated. A new insertion is most likely benign, 
very occasionally harmful, and with extreme rarity beneficial. 
However, over the course of eukaryote evolution some beneficial 
inserts have been retained, those harmful have been lost, and as 
a group transposable elements have contributed to chromosome 
architecture to the degree that we cannot really understand our 
own genome without understanding their biology.
Twenty years ago an unfortunate insertion into the factor VIII 
blood clotting gene caused hemophilia A in a boy and dem-
onstrated that L1s can be actively mobilized in human beings 
(Kazazian et al., 1988). Since then many researchers have 
been revealing the biology of retrotransposons in mammals. 
Progress has been due in large part to knowledge of mam-
malian genome sequences producing evolutionary insights, an 
assay for retrotransposition in cultured cells, and transgenic 
rodent models that allow analysis of retrotransposition in vivo. 
Although considerable new information has been obtained, 
progress on a number of key questions has been disappoint-
ing. We still have a rudimentary understanding of the biochem-
istry of insertion. We know little of the host factors important 
for retrotransposition. Our knowledge concerning when and 
in what cells most retrotransposition occurs is lacking. How-
ever, it is likely that these deficiencies will be eliminated with 
the emerging use of tiling arrays, massive cDNA transfection 
arrays, and high-throughput DNA sequencing, among others. 
We foresee an explosion of progress on the key questions and 
more complete understanding of the role of retrotransposons 
in the etiology of disease and the regulation of genes. Now it 
begins to get truly interesting.
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